The source of APRIL up-regulation in human solid tumor lesions.

Standard

The source of APRIL up-regulation in human solid tumor lesions. / Mhawech-Fauceglia, P; Kaya, G; Sauter, Guido; McKee, T; Donze, O; Schwaller, J; Huard, B.

in: J LEUKOCYTE BIOL, Jahrgang 80, Nr. 4, 4, 2006, S. 697-704.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Mhawech-Fauceglia, P, Kaya, G, Sauter, G, McKee, T, Donze, O, Schwaller, J & Huard, B 2006, 'The source of APRIL up-regulation in human solid tumor lesions.', J LEUKOCYTE BIOL, Jg. 80, Nr. 4, 4, S. 697-704. <http://www.ncbi.nlm.nih.gov/pubmed/16793914?dopt=Citation>

APA

Mhawech-Fauceglia, P., Kaya, G., Sauter, G., McKee, T., Donze, O., Schwaller, J., & Huard, B. (2006). The source of APRIL up-regulation in human solid tumor lesions. J LEUKOCYTE BIOL, 80(4), 697-704. [4]. http://www.ncbi.nlm.nih.gov/pubmed/16793914?dopt=Citation

Vancouver

Mhawech-Fauceglia P, Kaya G, Sauter G, McKee T, Donze O, Schwaller J et al. The source of APRIL up-regulation in human solid tumor lesions. J LEUKOCYTE BIOL. 2006;80(4):697-704. 4.

Bibtex

@article{25f50630cb6847718c65736ad1cfa6b3,
title = "The source of APRIL up-regulation in human solid tumor lesions.",
abstract = "Abundant mRNA expression for a proliferation-inducing ligand (APRIL) from tumor necrosis factor (TNF) family is observed in many solid tumors. Here, we analyzed in situ the cellular source of APRIL in human solid tumors with anti-APRIL antibodies. In most cases, neutrophils present in the tumor stroma constituted the main source of APRIL. In cutaneous lesions such as melanoma or basal cell carcinoma, tumor-adjacent keratinocytes also produced APRIL. APRIL production by tumor cells themselves was a rare event, only observed in urothelial bladder cancer and squamous cell carcinoma. Detailed analysis revealed that APRIL dissociated from producing cells, and secreted APRIL was retained in the tumor lesions. A direct binding onto tumor cells via heparan sulfate proteoglycans (HSPG) was observed in in vitro experiments and confirmed in situ. Taken together, our analysis indicates a potential role for HSPG/APRIL interactions in the development of solid tumors.",
author = "P Mhawech-Fauceglia and G Kaya and Guido Sauter and T McKee and O Donze and J Schwaller and B Huard",
year = "2006",
language = "Deutsch",
volume = "80",
pages = "697--704",
journal = "J LEUKOCYTE BIOL",
issn = "0741-5400",
publisher = "FASEB",
number = "4",

}

RIS

TY - JOUR

T1 - The source of APRIL up-regulation in human solid tumor lesions.

AU - Mhawech-Fauceglia, P

AU - Kaya, G

AU - Sauter, Guido

AU - McKee, T

AU - Donze, O

AU - Schwaller, J

AU - Huard, B

PY - 2006

Y1 - 2006

N2 - Abundant mRNA expression for a proliferation-inducing ligand (APRIL) from tumor necrosis factor (TNF) family is observed in many solid tumors. Here, we analyzed in situ the cellular source of APRIL in human solid tumors with anti-APRIL antibodies. In most cases, neutrophils present in the tumor stroma constituted the main source of APRIL. In cutaneous lesions such as melanoma or basal cell carcinoma, tumor-adjacent keratinocytes also produced APRIL. APRIL production by tumor cells themselves was a rare event, only observed in urothelial bladder cancer and squamous cell carcinoma. Detailed analysis revealed that APRIL dissociated from producing cells, and secreted APRIL was retained in the tumor lesions. A direct binding onto tumor cells via heparan sulfate proteoglycans (HSPG) was observed in in vitro experiments and confirmed in situ. Taken together, our analysis indicates a potential role for HSPG/APRIL interactions in the development of solid tumors.

AB - Abundant mRNA expression for a proliferation-inducing ligand (APRIL) from tumor necrosis factor (TNF) family is observed in many solid tumors. Here, we analyzed in situ the cellular source of APRIL in human solid tumors with anti-APRIL antibodies. In most cases, neutrophils present in the tumor stroma constituted the main source of APRIL. In cutaneous lesions such as melanoma or basal cell carcinoma, tumor-adjacent keratinocytes also produced APRIL. APRIL production by tumor cells themselves was a rare event, only observed in urothelial bladder cancer and squamous cell carcinoma. Detailed analysis revealed that APRIL dissociated from producing cells, and secreted APRIL was retained in the tumor lesions. A direct binding onto tumor cells via heparan sulfate proteoglycans (HSPG) was observed in in vitro experiments and confirmed in situ. Taken together, our analysis indicates a potential role for HSPG/APRIL interactions in the development of solid tumors.

M3 - SCORING: Zeitschriftenaufsatz

VL - 80

SP - 697

EP - 704

JO - J LEUKOCYTE BIOL

JF - J LEUKOCYTE BIOL

SN - 0741-5400

IS - 4

M1 - 4

ER -